Wizard Wellness, the brand treating allergy care with the same rigor and sensory appeal as skincare, today completed its national mass retail distribution across all three of the country’s largest mass retailers within four weeks, reaching more than 4,000 doors. The retail play comes after a significant funding round of over $1 million from new investors Pave Health Ventures and Vanquish Equity, joined by existing backers True Beauty Ventures and Barrier Island Capital.
The newest rollout in Target includes three SKUs: the Daily Probiotic Nasal Spray in Arctic Vanilla ($14.99), the Multi-Benefit Probiotic Oral Strips in Strawberry, 7-count ($10.99), and the Happy Nose Inhaler Stick in Glacial Mint ($9.99).
“Every store and every dollar gets us closer to making allergy care something people actually want to use, not just something they have to,” said Lorne Lucree, Founder and CEO of Wizard Wellness. “We believe your nose deserves the same daily care and thoughtful product design that transformed the skincare industry. Target is where that idea lands. Their customer is already buying serums and supplements on the same trip. We’re just asking her to extend that thinking into nasal wellness.”
The retail expansion and funding round follows a strong stretch for the brand’s direct-to-consumer growth:
- The brand’s subscription base has grown more than 17x since launch
- August 2026 was the brand’s largest DTC month yet
- Order value doubled in the July & August
- Repeat customer rate more than tripled in the last two months
About 40% of U.S. households report dealing with seasonal allergies, the top reported household health concern, according to NIQ, yet only 7% of consumers say they are satisfied with available products, per a 2025 Wizard Wellness survey of 596 U.S. consumers. Because 84 to 96% of allergy purchases happen in-store, depending on retailer, per Numerator, Wizard Wellness prioritized mass retail distribution early rather than spending an extended period building its online business first.
“Consumers are taking control of every part of their health journey, and allergy care has been overlooked for too long,” said Jacob Myers of Pave Health Ventures. “The demand is clear: people want clinically backed products wrapped in a brand they can trust and connect with. Wizard delivers exactly that, proven by a retail rollout that reached more than 4,000 doors in four weeks. That kind of traction, this early, is incredible. Pave is grateful to be part of the Wizard family.”
“One of the things we appreciated most about Wizard wasn’t just the product, but the way Lorne thought about building the business from first principles,” said Frank Woodbridge, Founder & Managing Partner, Vanquish Equity. “Rather than following the typical consumer startup playbook, he started with how people actually shop the category and built the strategy around that. It’s rare to see an early stage founder combine deep consumer insight, scientific credibility, and the discipline to execute a national retail rollout at this scale. We believe that combination gives Wizard the opportunity to build a brand that lasts, not simply one that captures attention.”
Wizard Wellness products are now available in approximately 1,000 Target stores nationwide and on Target.com, approximately 1,700 Walmart stores and Walmart.com, approximately 1,400 CVS locations and CVS.com, as well as on Amazon, TikTok Shop, and WizardWellness.com.
About Wizard Wellness
Wizard Wellness is the science-backed company that created the nasal wellness category. Founded in 2024 and launched in 2026 by beauty industry veteran Lorne Lucree, the company’s drug-free product system was formulated with ENT’s, allergists, and cutting-edge microbiome researchers to support the nasal barrier and microbiome through its proprietary Nasalbiome™ Technology. Wizard Wellness products are available at Target, Walmart, CVS, Amazon and WizardWellness.com. The company is backed by True Beauty Ventures, G9 Ventures, The Venture Collective, Able Partners, Barrier Island Capital, Pave Health Ventures and Vanquish Equity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260914106916/en/
Media gallery
